Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.81−0.09 (-4.74%)
Close on Nov 18, 2026Market cap $18.06MP/E –Yield –
Atossa Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Atossa Therapeutics's profit margin for the twelve months ending Sep 30, 2016 was -500957.3%. For fiscal 2015 it was -896491.6%, against -36518.8% the year before. The highest annual figure on record is -1054.3% in fiscal 2012.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | -896491.6% | −859972.8 |
| FY2014 | Dec 31, 2014 | -36518.8% | −34813.9 |
| FY2013 | Dec 31, 2013 | -1704.9% | −650.7 |
| FY2012 | Dec 31, 2012 | -1054.3% | +228430.3 |
| FY2011 | Dec 31, 2011 | -229484.5% | – |
See a number that looks wrong?